EP1322378A1 - Method and device for avoiding alteration of a substance having biological activities - Google Patents
Method and device for avoiding alteration of a substance having biological activitiesInfo
- Publication number
- EP1322378A1 EP1322378A1 EP01984149A EP01984149A EP1322378A1 EP 1322378 A1 EP1322378 A1 EP 1322378A1 EP 01984149 A EP01984149 A EP 01984149A EP 01984149 A EP01984149 A EP 01984149A EP 1322378 A1 EP1322378 A1 EP 1322378A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- substance
- treated
- treatment
- biological activity
- transducer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N37/00—Details not covered by any other group of this subclass
- G01N37/005—Measurement methods not based on established scientific theories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/16—Screening or neutralising undesirable influences from or using, atmospheric or terrestrial radiation or fields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Definitions
- the Treated Substance is called” Treated Water "(or even Informed Water).
- the substance with biological activity can also be present in the form of homeopathic preparations or granules.
- Treated Substances Informed to alter its properties. However, it is not possible to know a priori who are the people with such inhibitory effects.
- the transport and handling, by such people, of Treated Substances constitutes an obstacle (the activity is impaired) to the industrial development of these substances. This is the problem posed: to prevent disturbances from modifying the activity of a Treated Substance.
- the invention relates to a method for preventing the alteration of a substance having biological activities from a source substance which is no longer present in significant quantity.
- the method is applied to a substance exhibiting a biological activity, for example a coagulant or anticoagulant activity.
- the substance was obtained from a source substance with biological activity, at the end of a treatment such that the substance does not contain a molecule of the source substance in significant quantity
- the treatment may in particular consist in implementing a high dilution process of the same nature as that used to produce homeopathic solutions or granules.
- the treatment can also notably consist in putting in implements the process of Jacques Benveniste, comprising several stages, as described in patent N ° WO 00/17637 published on March 30, 2000 and having for title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect. Therapeutic applications of said substance or signal.
- It includes the step of transforming the electromagnetic field originating from the source substance having a biological activity, into a signal, in particular an electrical signal, by means of a transducer-receiver capturing the electromagnetic field.
- the source substance has, for example, an effect on blood clotting and may, for example, contain Ca ++ ions or heparin.
- the method further comprises the step of applying to a receptor substance, initially having no particular biological activity, the signal from the transducer-receiver, by means of a transducer-transmitter.
- the receptor substance initially having no particular biological activity, then exhibits coagulant or anticoagulant activity.
- the method is designed to protect the treated substance from external influences which it undergoes and is characterized in that it comprises the step of placing the treated substance in an enclosure, sheltered from electromagnetic fields.
- the enclosure is surrounded by a magnetic shield made of soft iron or mumetal.
- the invention also relates to a device applied to a substance having a biological activity, for example a coagulant or anticoagulant activity.
- the substance was obtained from a source substance with biological activity, after a treatment such that the substance does not contain a molecule of the source substance in significant quantity (the substance is hereinafter called the substance being treated).
- the processing may notably consist in implementing a high dilution process of the same nature as that used to produce homeopathic solutions or granules.
- the treatment can also in particular consist in implementing the method of Jacques Benveniste, comprising several stages, as described in patent N ° WO 00/17637 published on March 30, 2000 and having for title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect.
- Therapeutic applications of said substance or of said signal includes the step of transforming the electromagnetic field originating from the source substance having a biological activity, into a signal, in particular an electrical signal, by means of a transducer-receiver capturing the electromagnetic field.
- the source substance has, for example, an effect on blood clotting and may, for example, contain Ca ++ ions or heparin.
- It further comprises the step of applying to a receptor substance, initially having no particular biological activity, the signal from the transducer-receiver, by means of a transducer-transmitter.
- the receptor substance initially having no particular biological activity, then exhibits coagulant or anticoagulant activity.
- the device is designed to protect the treated substance from external influences which it undergoes and is characterized in that it comprises the step of placing the treated substance in an enclosure, sheltered from electromagnetic fields.
- the enclosure is surrounded by a magnetic shield made of soft iron or mumetal.
- FIG. 3 presenting a schematic view of the method and of the device according to the invention, making it possible to avoid the alteration of a substance with biological activities.
- FIG. 1 and 2 a system according to that described in patent No. WO 00/17637 published March 30, 2000 and having as title "Method and system for producing a substance or a signal having a coagulant or anticoagulant effect Therapeutic applications of said substance or signal. " The system makes it possible to produce, from a mother substance, electrical signals, characteristic of its biological activity. In the present case, the parent substance is heparin 1 having an anticoagulant effect.
- the system comprises a cylindrical enclosure 2, provided with a shielding isolating the enclosure 2 from parasitic fields coming from the environment.
- the enclosure 2 is closed by a cover 5 also shielded.
- a transmitter 4 is located inside the enclosure. It generates a determined excitation field of an electromagnetic nature.
- the transmitter is powered by a generator 7 designed to generate a low frequency signal, in particular square or sinusoidal low frequency signals, pink noise or, advantageously, white noise.
- the generator 7 takes the form of a microcomputer 7, provided with a sound card comprising an analog-digital converter.
- the converter has an output terminal 8.
- the output terminal 8 of the microcomputer sound card 7 is connected to the input terminal 8a of the transmitter 4, via an amplifier 9.
- a plastic tank 3 containing 1 ml of heparin as well as a transducer-receptor 6.
- the transducer- receiver 6 receives the fields resulting from the interaction of the specific excitation field and heparin 1.
- the transducer-receiver 6 transforms these fields into electrical signals. These electrical signals are present, at the output 10 of the transducer-receiver 6, in the form of a variable potential difference or an electric current of variable intensity.
- the electrical signals available at the output 10 of the transducer-receiver 6 are amplified by a preamplifier 11.
- the electrical signals, after analog-digital conversion, are subject to digital recording.
- a microcomputer 7a is used, of the same type as the microcomputer 7, comprising an analog-digital converter.
- the output 10 of the transducer-receiver 6 is connected to the input 10a of the analog-digital converter of the microcomputer 7a, via the preamplifier 11.
- the system allows to produce "informed water” from the electrical signals obtained as described above.
- a plastic tank 14 is placed a receiving substance which initially exhibits no particular biological activity, in particular water.
- This tank 14 is arranged in an electromagnetic field radiated by a transducer-transmitter 13, in this case a coil 13.
- the input terminals 12 of the coil 13 are connected to the output 12a of an analog-digital converter of a microcomputer 15, via an amplifier 16.
- the microcomputer 15 stores in memory the electrical signals digitized by means of the microcomputer 7.
- the microcomputer 15 comprising the analog-digital converter is similar to the microcomputer 7, previously described.
- the analog-to-digital converter produces electrical signals from digital recording.
- the water thus obtained is susceptible of industrial applications, provided that its properties are not altered.
- certain individuals have an inhibiting or, conversely, potentiating effect on informed water, in particular when they handle a tube containing informed water.
- FIG. 3 presents a schematic view of the method and of the system according to the invention, making it possible to avoid the alteration of a substance having biological activities.
- potential alterations is meant the inhibitory or potentiating effect that an individual can produce on informed water, by manipulating the tube which contains it or by approaching near this tube.
- a tube 17a contains informed water with anticoagulant activity. The informed water was previously produced as described above.
- the tube 17a which contains it is placed in an enclosure 19, in order to protect it from electromagnetic fields.
- the enclosure 19 is surrounded by a magnetic shield 19a, made of soft iron or mumetal.
- the tube 17a is located sheltered from potential alterations, in particular from alterations by an individual producing an inhibiting or potentiating effect on informed water.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0009169A FR2811591B1 (en) | 2000-07-12 | 2000-07-12 | METHOD AND DEVICE FOR PREVENTING THE ALTERATION OF A SUBSTANCE HAVING BIOLOGICAL ACTIVITIES |
FR0009169 | 2000-07-12 | ||
PCT/FR2001/002172 WO2002004067A1 (en) | 2000-07-12 | 2001-07-05 | Method and device for avoiding alteration of a substance having biological activities |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1322378A1 true EP1322378A1 (en) | 2003-07-02 |
Family
ID=8852446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01984149A Ceased EP1322378A1 (en) | 2000-07-12 | 2001-07-05 | Method and device for avoiding alteration of a substance having biological activities |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040038937A1 (en) |
EP (1) | EP1322378A1 (en) |
AU (1) | AU2002218753A1 (en) |
FR (1) | FR2811591B1 (en) |
WO (1) | WO2002004067A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2894673B1 (en) * | 2005-12-14 | 2014-10-31 | Luc Montagnier | METHOD FOR CHARACTERIZING A BIOCHEMICAL ELEMENT HAVING BIOLOGICAL ACTIVITY BY ANALYZING LOW FREQUENCY ELECTROMAGNETIC SIGNALS |
FR2902883B1 (en) * | 2006-06-22 | 2008-09-12 | Nanectis Biotechnologies | METHOD FOR DETECTING MICROORGANISM WITHIN A SAMPLE |
US8405379B1 (en) | 2008-09-18 | 2013-03-26 | Luc Montagnier | System and method for the analysis of DNA sequences in biological fluids |
CN102711911A (en) * | 2009-11-20 | 2012-10-03 | 埃托里有限责任公司 | Method for the remote transmission of an energy information signal from animate and inanimate objects and energy information signal converter |
WO2015082964A1 (en) * | 2013-12-06 | 2015-06-11 | Germanov Evgenij Pavlovich | Device for the remote transmission of a representative value of electromagnetic radiation emitted by a material and methods for operating the device |
EP3847708A4 (en) * | 2018-09-04 | 2022-07-20 | Daramic, LLC | Battery separators, electrode assemblies, systems and related methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2449951A1 (en) * | 1979-02-23 | 1980-09-19 | Ohresser Gerard | Radiation adsorption equipment - comprises straight parallel tubes contg. adsorbent material around space to be isolated |
US4287543A (en) * | 1979-12-31 | 1981-09-01 | American Optical Corporation | Tape head mount |
FR2634381B1 (en) * | 1988-07-25 | 1990-09-07 | Morez Jean Bernard | PROCESS FOR THE MANUFACTURE OF HOMEOPATHIC DRUGS IN A SINGLE OPERATION WHATEVER THE DILUTION SELECTED |
IT1290779B1 (en) * | 1995-06-26 | 1998-12-10 | Antonio Sacchetti | PROCEDURE FOR THE ENHANCEMENT OF THE THERAPEUTIC ACTIVITIES OF NATURAL SUBSTANCES (VITAMINS, MINERALS, HERBS, PHYTO-PREPARATIONS, FOODS) |
DE19713821A1 (en) * | 1997-04-03 | 1998-10-15 | Ralf Riba | Portable structure for protecting against electromagnetic radiation |
FR2783606B1 (en) * | 1998-09-23 | 2000-11-24 | Digibio | METHOD AND SYSTEM FOR PRODUCING A SUBSTANCE OR SIGNAL HAVING A COAGULATING OR ANTICOAGULATING EFFECT. THERAPEUTIC APPLICATIONS OF SAID SUBSTANCE OR SIGNAL |
FR2783605A1 (en) * | 1998-09-23 | 2000-03-24 | Digibio | Production of electromagnetic signals from a biological or chemical sample, characteristic of their active ingredients, which can then be transmitted to a remote location |
-
2000
- 2000-07-12 FR FR0009169A patent/FR2811591B1/en not_active Expired - Fee Related
-
2001
- 2001-07-05 EP EP01984149A patent/EP1322378A1/en not_active Ceased
- 2001-07-05 AU AU2002218753A patent/AU2002218753A1/en not_active Abandoned
- 2001-07-05 US US10/332,609 patent/US20040038937A1/en not_active Abandoned
- 2001-07-05 WO PCT/FR2001/002172 patent/WO2002004067A1/en active Application Filing
Non-Patent Citations (8)
Title |
---|
BENVENISTE J.: "Transfer of Biological Activity by Electromagnetic Fields", FRONTIER PERSPECTIVES, vol. 3, no. 2, 1993, pages 13 - 15, XP008059326 * |
BENVENISTE J.; GUILLONET D.: "QED and Digital Biology", RIVISTA DI BIOLOGIA, vol. 97, no. 1, 2004, pages 169 - 172, XP008059428 * |
EINSTEIN A.: "Über die von der molekularkinetischen Theorie der Wärme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen", ANNALEN DER PHYSIK, vol. 17, 1905, pages 549 - 560 * |
PARK R.: "Voodoo Science", OXFORD UNIVERSITY PRESS, 00-00-2000 * |
SCHWEITZER J.; ELLERINGMANN S.: "Homöopathie", STERN, 12 February 2004 (2004-02-12), HAMBURG, DE, pages 117 - 127 * |
See also references of WO0204067A1 * |
WANJEK C.: "Bad Medicine", 2003, WILEY, USA * |
Website http://www.bbc.co.uk/science/2002/homeopathy.shtml, published 2002, retreived 12.02.2004 * |
Also Published As
Publication number | Publication date |
---|---|
FR2811591B1 (en) | 2014-11-07 |
WO2002004067A1 (en) | 2002-01-17 |
AU2002218753A1 (en) | 2002-01-21 |
FR2811591A1 (en) | 2002-01-18 |
US20040038937A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1116025A1 (en) | Method, system and device for producing signals from a substance, in particular electric signals, characteristic of said substance biological and/or chemical activity | |
Spindler et al. | Enhancement of latent fingermarks on non-porous surfaces using anti-l-amino acid antibodies conjugated to gold nanoparticles | |
Vallecillos et al. | Determination of musk fragrances in sewage sludge by pressurized liquid extraction coupled to automated ionic liquid‐based headspace single‐drop microextraction followed by GC‐MS/MS | |
CA2554109C (en) | Device for detecting unauthorized objects in a protected access area | |
EP1322378A1 (en) | Method and device for avoiding alteration of a substance having biological activities | |
EP1112748A2 (en) | Method and device for transmitting the biological activity of a carrier material as a signal to another carrier material, and for processing said signal, and product thereby obtained | |
FR2911212A1 (en) | DETECTOR OF PRODUCTS NOT ALLOWED IN A PROTECTED ACCESS ZONE | |
Kostrewa et al. | Surface‐enhanced Raman scattering on molecularly imprinted polymers in water | |
EP1136845B1 (en) | Circuit for detecting the presence of a permanent magnet near to an active medical device | |
Prydz et al. | Radiation induced free radicals in alanine and some related amino acids. Electron spin resonance studies | |
WO2000017637A1 (en) | Method and system for producing a substance or a signal with coagulating or anticoagulant effect | |
WO2002004958A1 (en) | Method for determining potential alterations of a substance having biological activities | |
Doi et al. | Characterization of the decomposition of compounds derived from imidazolidinyl urea in cosmetics and patch test materials | |
Lardone et al. | Inverse correlation between endogenous melatonin levels and oxidative damage in some tissues of SAM P8 mice | |
FR2639122A1 (en) | METHOD AND APPARATUS FOR DETECTING PULSES DUE TO ELECTROSTATIC DISCHARGES | |
Grizzle | Theory and practice of silver staining in histopathology | |
Radi et al. | Determination of Esomeprazole on an Electropolymerized L‐arginine and β‐cyclodextrin Modified Screen Printed Carbon Electrode | |
Nasimova et al. | Poly (N‐vinylcaprolactam) gel/organic dye complexes as sensors for metal ions in aqueous salt solutions | |
Oppenheim et al. | Relationship of rotational correlation time from EPR spectroscopy and protein-membrane interaction | |
Yoshitake et al. | Autoxidation of ascorbate mediates lysine N-pyrrolation | |
FR2578412A1 (en) | METHOD AND DEVICE FOR RECOGNIZING AN INDIVIDUAL | |
FR3008492A1 (en) | RADIATION DOSIMETER AND SPECTROSCOPY RPE DOSE MEASUREMENT METHOD | |
FR2914060A1 (en) | DEVICE AND METHOD FOR MEASURING THE MASS OF MAGNETIC MATERIAL, ANALYSIS APPARATUS INCORPORATING SAID DEVICE | |
AU2002325141A1 (en) | Method and device for measuring changes in microviscosity serving as an immune test | |
Çubuk et al. | UV cured polymeric optical fluorescence sensor for the determination of Au (III) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030110 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17Q | First examination report despatched |
Effective date: 20040224 |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20090901 |